Skip to Main Content

Paper Details

Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma.
Brain Commun
22
2020
DBK-1154, Glioblastoma, NZ-8-061, Tumour, cancer, cancer drivers, cell lines, glioblastoma, glioblastoma cell, glioblastoma cell lines, glioblastoma cells, glioblastoma tumours, glioma, mice, mouse, patient, primary glioma, protein phosphatase 2A, tumour, tumour suppressor, tumour suppressors
Author NameAffiliation
David B KastrinskyIcahn School of Medicine at Mount Sinai
David B KastrinskyDonald and Barbara Zucker School of Medicine at Hofstra/Northwell
Nilesh ZawareIcahn School of Medicine at Mount Sinai
Goutham NarlaUniversity of Michigan ann arbor
Goutham NarlaUniversity of Michigan ann arbor
Michael OhlmeyerIcahn School of Medicine at Mount Sinai
Michael OhlmeyerAtux Iskay LLC
Michael OhlmeyerIcahn School of Medicine at Mount Sinai
Michael OhlmeyerAtux Iskay LLC
  • 1 - 9

Datasets

Release 1.2